Brent Korba

514 total citations
22 papers, 410 citations indexed

About

Brent Korba is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Brent Korba has authored 22 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 10 papers in Infectious Diseases and 9 papers in Hepatology. Recurrent topics in Brent Korba's work include Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (7 papers) and HIV/AIDS drug development and treatment (6 papers). Brent Korba is often cited by papers focused on Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (7 papers) and HIV/AIDS drug development and treatment (6 papers). Brent Korba collaborates with scholars based in United States, Pakistan and France. Brent Korba's co-authors include Bud C. Tennant, Katherine L. Seley‐Radtke, Stewart W. Schneller, David M. Lansky, Baruch S. Blumberg, Raymond A. Dwek, Timothy M. Block, Xuanyong Lu, Anand S. Mehta and Gary S. Jacob and has published in prestigious journals such as Nature Medicine, Hepatology and Journal of Virology.

In The Last Decade

Brent Korba

22 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brent Korba United States 13 217 171 143 134 78 22 410
Jean–Marc Juteau United States 9 205 0.9× 81 0.5× 131 0.9× 141 1.1× 14 0.2× 14 428
Brenda I. Hernández-Santiago United States 9 167 0.8× 307 1.8× 143 1.0× 119 0.9× 39 0.5× 16 451
Ona Barauskas United States 9 183 0.8× 244 1.4× 142 1.0× 154 1.1× 27 0.3× 15 513
Anna Boguszewska‐Chachulska Poland 11 98 0.5× 99 0.6× 148 1.0× 121 0.9× 45 0.6× 26 369
Karen Rigat United States 10 262 1.2× 193 1.1× 115 0.8× 363 2.7× 54 0.7× 13 511
D. F. SMEE United States 8 282 1.3× 168 1.0× 101 0.7× 22 0.2× 50 0.6× 12 476
Jérôme Deval United States 8 118 0.5× 237 1.4× 146 1.0× 36 0.3× 35 0.4× 13 402
Anna Offersgaard Denmark 11 85 0.4× 226 1.3× 94 0.7× 74 0.6× 28 0.4× 18 406
Darius Bilimoria Canada 10 171 0.8× 220 1.3× 161 1.1× 320 2.4× 55 0.7× 11 472
Tatiana Tolstykh United States 8 132 0.6× 162 0.9× 216 1.5× 150 1.1× 30 0.4× 10 448

Countries citing papers authored by Brent Korba

Since Specialization
Citations

This map shows the geographic impact of Brent Korba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brent Korba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brent Korba more than expected).

Fields of papers citing papers by Brent Korba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brent Korba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brent Korba. The network helps show where Brent Korba may publish in the future.

Co-authorship network of co-authors of Brent Korba

This figure shows the co-authorship network connecting the top 25 collaborators of Brent Korba. A scholar is included among the top collaborators of Brent Korba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brent Korba. Brent Korba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loffredo, Christopher A., et al.. (2022). Correlates and Covariates of Type 2 Diabetes in an African American Population in the Washington DC Area. Open Journal of Epidemiology. 12(4). 431–448. 1 indexed citations
2.
Loffredo, Christopher A., et al.. (2022). Insights on the pathogenesis of type 2 diabetes as revealed by signature genomic classifiers in an African American population in the Washington, DC area. Diabetes/Metabolism Research and Reviews. 39(1). e3589–e3589. 5 indexed citations
3.
4.
Saleh, Doa’a A., Sameera Ezzat, Mohamed Abdel‐Hamid, et al.. (2015). Viral transmission risk factors in an Egyptian population with high hepatitis C prevalence. BMC Public Health. 15(1). 1030–1030. 17 indexed citations
5.
Castro, Sonia de, Graciela Andreï, Robert Snoeck, et al.. (2015). Conservation of antiviral activity and improved selectivity in PMEO-DAPym upon pyrimidine to triazine scaffold hopping. Antiviral Research. 122. 64–68. 2 indexed citations
6.
May, Jared P., et al.. (2014). The P4-P2′ Amino Acids Surrounding Human Norovirus Polyprotein Cleavage Sites Define the Core Sequence Regulating Self-Processing Order. Journal of Virology. 88(18). 10738–10747. 8 indexed citations
7.
May, Jared P., et al.. (2013). Enzyme kinetics of the human norovirus protease control virus polyprotein processing order. Virology. 444(1-2). 218–224. 14 indexed citations
8.
Rawal, Ravindra K., Uma S. Singh, Jianing Wang, et al.. (2012). 2′-Fluoro-6′-methylene-carbocyclic adenosine phosphoramidate (FMCAP) prodrug: In vitro anti-HBV activity against the lamivudine–entecavir resistant triple mutant and its mechanism of action. Bioorganic & Medicinal Chemistry Letters. 23(2). 503–506. 15 indexed citations
9.
10.
Iyer, Radhakrishnan P., John E. Coughlin, Seetharamaiyer Padmanabhan, Brent Korba, & Sua Myong. (2010). Activation of Retinoic Acid Inducible Gene (RIG-I) by Nucleotide Analogs: A Potential Novel Mechanism for Antiviral Discovery. Antiviral Research. 86(1). A35–A35. 3 indexed citations
11.
Korba, Brent, et al.. (2010). Synthesis of a Series of 2′-Modified Tricyclic Nucleosides as Potential HCV Agents. Antiviral Research. 86(1). A68–A68. 1 indexed citations
12.
Bryant, Martin L., Edward G. Bridges, L Placidi, et al.. (2001). ANTI-HBV SPECIFIC β-L-2′-DEOXYNUCLEOSIDES. Nucleosides Nucleotides & Nucleic Acids. 20(4-7). 597–607. 23 indexed citations
13.
Block, Timothy M., Xuanyong Lu, Anand S. Mehta, et al.. (1998). Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking. Nature Medicine. 4(5). 610–614. 125 indexed citations
14.
Seley‐Radtke, Katherine L., Stewart W. Schneller, & Brent Korba. (1998). Does the Anti-Hepatitis B Virus Activity of (+)-5‘-Noraristeromycin Exist in Its 4‘-Epimer and 4‘-Deoxygenated Derivatives?. Journal of Medicinal Chemistry. 41(12). 2168–2170. 14 indexed citations
15.
Seley‐Radtke, Katherine L., Stewart W. Schneller, & Brent Korba. (1997). A 5′-Noraristeromycin Enantiomer with Activity Towards Hepatitis B Virus. Nucleosides and Nucleotides. 16(12). 2095–2099. 31 indexed citations
16.
Girardet, Jean‐Luc, Alain Pompon, Christian Périgaud, et al.. (1997). The Pronucleotide Approach. III. Synthesis, Anti-HBV Activity and Stability Studies of the Bis(S-pivaloyl-2-thioethyl) Phosphotriester Derivative of Acyclovir. Nucleosides and Nucleotides. 16(7-9). 1331–1335. 5 indexed citations
17.
Hostetler, Karl Y., et al.. (1997). Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis b virus infection, in vitro. Biochemical Pharmacology. 53(12). 1815–1822. 37 indexed citations
18.
Korba, Brent, Hong Xie, William E. Hornbuckle, et al.. (1996). Liver-targeted antiviral nucleosides: Enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infection in vivo. Hepatology. 23(5). 958–963. 29 indexed citations
19.
Xie, Hong, Michael Voronkov, Dennis C. Liotta, et al.. (1995). Phosphatidyl-2′,3′-dideoxy-3′-thiacytidine: synthesis and antiviral activity in hepatitis B- and HIV-1-infected cells. Antiviral Research. 28(2). 113–120. 20 indexed citations
20.
Korba, Brent, Bud C. Tennant, Paul J. Côté, & John L. Gerin. (1991). Treatment of chronic carriers of woodchuck hepatitis virus infection with thymosin alpha-1. Antiviral Research. 15. 131–131. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean–Marc Juteau Breakdown of academic impact, for papers by Brenda I. Hernández-Santiago Breakdown of academic impact, for papers by Ona Barauskas Breakdown of academic impact, for papers by Anna Boguszewska‐Chachulska Breakdown of academic impact, for papers by Karen Rigat Breakdown of academic impact, for papers by D. F. SMEE Breakdown of academic impact, for papers by Jérôme Deval Breakdown of academic impact, for papers by Anna Offersgaard Breakdown of academic impact, for papers by Darius Bilimoria Breakdown of academic impact, for papers by Tatiana Tolstykh
Rankless by CCL
2026